The trigger is one small injection at the end of stimulation — and most of the cycle outcome rides on it. The talk walks through HCG, GnRH agonist, dual and double trigger strategies, the Vienna consensus 80-95% oocyte yield target, and the practical decisions that connect trigger choice to oocyte maturation in real protocols.
HCG remains the workhorse trigger but extends LH-like activity over 6-7 days, driving the progesterone surge in fresh cycles. Agonist trigger gives a much shorter LH peak (24-28 hours) and a steep luteal-phase drop — needs rescue if transferring fresh. Dual trigger (agonist + HCG) recovers oocyte maturation in cases with low yield-per-follicle ratio. The Vienna consensus oocyte-yield target of 80-95% of antral follicles is a usable lab quality marker.
Match trigger choice to the cycle plan: HCG for fresh transfer with full luteal-phase support; agonist trigger for freeze-all and OHSS risk; dual trigger when prior cycle showed a low yield-to-follicle ratio. Audit your lab against the 80-95% Vienna target and identify whether deviations come from stimulation, trigger timing or aspiration technique.
Empty follicle syndrome can present even with a correctly administered trigger — check LH stick or progesterone in suspicious cases. Trigger timing affects maturation more than dose at modern doses. HMG-derived LH activity does not match recombinant LH or HCG one-to-one.
The dual trigger (GnRH agonist + low-dose hCG) combines the advantages: a physiological surge and luteal-phase support. The double trigger — administering two stimuli at an interval (for example, 40 and 34 hours before retrieval) — is used when the oocyte immaturity index is high, to synchronize final maturation.
The Vienna consensus sets a target benchmark of efficiency: the proportion of mature oocytes (yield) should be around 80–95% of the number of follicles ≥12–14 mm. A downward deviation is a signal to reconsider the timing, dose and type of trigger.
Timing is critical: the trigger is given when there is a sufficient number of leading follicles, and retrieval after a strictly calibrated interval matching the kinetics of meiosis resumption and cumulus expansion. An error in timing directly reduces the proportion of mature MII oocytes.
Empty follicle syndrome — the absence of oocytes when aspirating visually mature follicles — is more often related to pharmacokinetics or a trigger administration error than to true pathology. The analysis of its causes closes the logic of the lecture: the right trigger at the right time is the key to oocyte quality.
The trigger is one small injection at the end of stimulation — and most of the cycle outcome rides on it. A practical walk through trigger choice (HCG, agonist, dual, double), the Vienna consensus 80-95% oocyte yield ratio, and what each trigger does to oocyte maturation in real protocols.
-1.png&w=3840&q=75)
